Baus-Domínguez
M, Gómez-Díaz R, Martín-Lozano G, Iglesias-Martín F, Gutiérrez-Pérez JL,
Torres-Lagares D, Serrera-Figallo MA, Gutiérrez-Corrales A. Detection of NOTCH1
mutations in paraffin samples in patients with potentially malignant lesions. J
Clin Exp Dent. 2023;15(3):e177-86.
doi:10.4317/jced.60293
https://doi.org/10.4317/jced.60293
__________
References
1.
Wu-Chou YH, Hsieh CC, Liao KT, Lin KT, Fan WL, Yang HC. NOTCH1 mutations as
prognostic marker in oral squamous cell carcinoma. Pathol Res Pract. 2021;223:153474. |
|
|
|
2.
da Cunha Lima AM, Meira IA, Soares MSM, Bonan PRF, Mlo CB, Piagge CSLD. Delay
in diagnosis of oral cancer: A systematic review. Med Oral Patol Oral and Cir
Bucal. 2021;26:e815-24. |
|
|
|
3.
Ding X, Zheng Y, Wang Z, Zhang W, Dong Y, Chen W, et al. Expression and
oncogenic properties of membranous Notch1 in oral leukoplakia and oral
squamous cell carcinoma. Oncol Rep. 2018;39:2584-94. |
|
|
|
4.
Sakamoto K. Notch signaling in oral squamous neoplasia. Pathol Int. 2016;66:609-17. |
|
|
|
5.
Farah CS. Molecular landscape of head and neck cancer and implications for
therapy. Ann Transl Med. 2021;9:915-915. |
|
|
|
6.
Yap L, Lee D, Khairuddin A, Pairan M, Puspita B, Siar C, et al. The opposing
roles of NOTCH signalling in head and neck cancer: a mini review. Oral Dis.
2015;21:850-7. |
|
|
|
7.
Kujan O, Huang G, Ravindran A, Vijayan M, Farah CS. CDK4, CDK6, cyclin D1 and
Notch1 immunocytochemical expression of oral brush liquid-based cytology for
the diagnosis of oral leukoplakia and oral cancer. J Oral Pathol Med. 2019;48:566-73. |
|
|
|
8.
BARAKAT SMM, SIAR CH. Differential expression of stem cell-like proteins in
normal, hyperplastic and dysplastic oral epithelium. J Appl Oral Sci. 2015;23:79-86. |
|
|
|
9.
Prime SS, Cirillo N, Cheong SC, Prime MS, Parkinson EK. Targeting the genetic
landscape of oral potentially malignant disorders has the potential as a
preventative strategy in oral cancer. Cancer Lett. 2021;518:102-14. |
|
|
|
10.
Hsu PJ, Yan K, Shi H, Izumchenko E, Agrawal N. Molecular biology of oral
cavity squamous cell carcinoma. Oral Oncol. 2020;102:104552. |
|
|
|
11.
Ada Hamosh (January 25, 2021). NOTCH RECEIVER 1 NOTCH1. Online Mendelian
Inheritance in Man® Retrieved on December 29, 2021.
https://www.omim.org/entry/190198?search=NOTCH1&highlight=notch1 |
|
12.
de Freitas Filho SAJ, Coutinho-Camillo CM, Oliveira KK, Bettim BB, Pinto CAL,
Kowalski LP, et al. Prognostic Implications of ALDH1 and Notch1 in Different
Subtypes of Oral Cancer. Santhekadur PK, editor. J Oncol. 2021;2021:1-9. |
|
|
|
13.
Sharma V, Nandan A, Sharma AK, Singh H, Bharadwaj M, Sinha DN, et al.
Signature of genetic associations in oral cancer. Biol Tumor. 2017;39:101042831772592. |
|
|
|
14.
Tang S, Xu D, Zho B. Analysis of P53 mutation and invasion front grading in
oral squamous cell carcinomas. J Huazhong Univ Sci Technolog Med Sci. 2010;30:525-9. |
|
|
|
15.
Martín-Lozano G, Gómez-Díaz R, Iglesías-Martín F, Torres-Lagares D,
Gutiérrez-Corrales A, Gutiérrez-Pérez J. Mutations in p53 Gene Exons in a
Sample from the South of Spain in Oral Cancer. J Clin Exp Dent. 2021;13:e1001-5. |
|
|
|
16.
Song X, Xia R, Li J, Long Z, Ren H, Chen W, et al. Common and complex Notch1
mutations in Chinese oral squamous cell carcinoma. Clin Cancer Res. 2014;20:701-10. |
|
|
|
17.
Wang S, Fan H, Xu J, Zhao E. Prognostic implication of NOTCH1 in early stage
oral squamous cell cancer with occult metastases. Clin Oral Investig. 2018;22:1131-1138. |
|
|
|
18.
Zhang TH, Liu HC, Zhu LJ, Chu M, Liang YJ, Liang LZ, et al. Activation of
Notch signaling in human tongue carcinoma. J Oral Pathol Med. 2011;40:37-45. |
|
|
|
19.
Zhang T, Liang L, Liu X, Wu JN, Chen J, Su K, et al.
TGFβ1-Smad3-Jagged1-Notch1-Slug signaling pathway takes part in tumorigenesis
and progress of tongue squamous cell carcinoma. J Oral Pathol Med. 2016;45:486-93. |
|
|
|
20.
Sakamoto K, Fujii T, Kawachi H, Miki Y, Omura K, Morita K, et al. Reduction
of NOTCH1 expression pertains to maturation abnormalities of keratinocytes in
squamous neoplasms. Lab Invest. 2012 May;92(5):688-702. |